Cargando…
Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome
Fatty acid synthase (FASN) expression is elevated in several cancers, and this over-expression is associated with poor prognosis. Inhibitors of FASN, such as orlistat, reportedly show antitumor effects against cancers that over-express FASN, making FASN a promising therapeutic target. However, large...
Autores principales: | Yoshii, Yukie, Furukawa, Takako, Oyama, Nobuyuki, Hasegawa, Yoko, Kiyono, Yasushi, Nishii, Ryuichi, Waki, Atsuo, Tsuji, Atsushi B., Sogawa, Chizuru, Wakizaka, Hidekatsu, Fukumura, Toshimitsu, Yoshii, Hiroshi, Fujibayashi, Yasuhisa, Lewis, Jason S., Saga, Tsuneo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669310/ https://www.ncbi.nlm.nih.gov/pubmed/23741342 http://dx.doi.org/10.1371/journal.pone.0064570 |
Ejemplares similares
-
Controlled Administration of Penicillamine Reduces Radiation Exposure in Critical Organs during (64)Cu-ATSM Internal Radiotherapy: A Novel Strategy for Liver Protection
por: Yoshii, Yukie, et al.
Publicado: (2014) -
Mutant phenotype analysis suggests potential roles for C-type natriuretic peptide receptor (NPR-B) in male mouse fertility
por: Sogawa, Chizuru, et al.
Publicado: (2014) -
(64)Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts
por: Yoshii, Yukie, et al.
Publicado: (2017) -
Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe (64)Cu-cyclam-RAFT-c(-RGDfK-)(4)
por: Jin, Zhao-Hui, et al.
Publicado: (2012) -
Process to Remove the Size Variants Contained in the Antibody–Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64
por: Yoshii, Yukie, et al.
Publicado: (2023)